<DOC>
	<DOCNO>NCT01659398</DOCNO>
	<brief_summary>The aim study investigate whether enhanced external counterpulsation ( EECP ) therapy 7 consecutive week improve cerebral blood flow possibly time enhance slow breakdown cognitive function patient diagnose mild cognitive impairment ( MCI ) .</brief_summary>
	<brief_title>Enhanced External Counterpulsation Its Effects Vascular Hemodynamics Cognitively Impaired Patients</brief_title>
	<detailed_description />
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<criteria>An adult 18 85 year age . Has evaluate CDR ( Clinical Dementia Rating ) Score 0.5 Male female ( female must postmenopausal least 1 year , surgically sterile use effective form contraception ) . Able speak read English . Willing comply study specific instruction , complete study procedure accord protocol . Able understand study rationale sign inform consent . Diagnosed glaucoma History develop adverse effect ophthalmic dilate agent ( phenylephrine tropicamide ) . Currently take warfarin dabigatran ( Pradaxa ) . History arrhythmia interfere EECP trigger . Subject bleed diathesis . Subject active thrombophlebitis . Subject severe low extremity vasoocclusive disease . Subject document aortic aneurysm require surgical repair . Subject pregnant . Subject blood pressure high 180/110 mmHg . Subject heart rate 120 bpm . Subject high risk complication increase venous return . Subject clinically significant valvular disease . Subjects severe vascular disease establish Hachinski Ischemic Index . Subjects pacemaker metallic implantable device .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Alzheimer 's Disease</keyword>
	<keyword>cerebral blood flow</keyword>
	<keyword>ophthalmic blood flow</keyword>
	<keyword>blood viscosity</keyword>
</DOC>